Plant Hormone Modulation for Sustainable Agriculture
Legal Citation
Summary of the Inventive Concept
The inventive concept applies the core technology of the original patent to the field of agriculture, utilizing a pharmaceutical composition comprising an antibody, glycine, acetate buffer, and polysorbate 80 to modulate plant hormones and improve crop yields, reduce water consumption, increase shelf life, monitor plant health, and reduce pesticide use.
Background and Problem Solved
The original patent focused on pharmaceutical formulations for human health, but the limitations of current agricultural practices, such as low crop yields, high water consumption, and excessive pesticide use, necessitate innovative solutions. The new inventive concept addresses these challenges by adapting the original patent's technology to the agricultural industry.
Detailed Description of the Inventive Concept
The pharmaceutical composition, comprising an antibody that specifically binds to a plant hormone, glycine, acetate buffer, and polysorbate 80, is applied to plants in various forms, such as sprays, injections, or soil amendments. This modulates plant hormone activity, leading to improved crop yields, reduced water consumption, increased shelf life, enhanced plant health monitoring, and decreased pesticide use. The antibody's specific binding properties allow for targeted modulation, minimizing environmental impact and maximizing agricultural benefits.
Novelty and Inventive Step
The new inventive concept's novelty lies in its application of the original patent's technology to the agricultural industry, specifically modulating plant hormones to address pressing agricultural challenges. The inventive step resides in the unexpected use of an antibody-based pharmaceutical composition in agriculture, which provides a non-obvious solution to the problems faced by the industry.
Alternative Embodiments and Variations
Alternative embodiments could include using different antibodies or antibody fragments, varying the composition's formulation, or incorporating additional components to enhance its effects. Variations could involve applying the composition to different plant species, using it in conjunction with other agricultural practices, or developing new methods for large-scale production and distribution.
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in the agricultural industry, with applications in crop production, plant breeding, and agricultural services. The target market includes agricultural companies, farmers, and governments seeking to improve crop yields, reduce environmental impact, and increase food security.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K39/39591 |
| A | A61 | A61K47/12 |
| A | A61 | A61K47/183 |
| A | A61 | A61K47/26 |
| C | C07 | C07K16/244 |
| C | C07 | C07K2317/76 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Biotechnology and pharmaceutical formulations, with specific expertise in antibody composition design, protein engineering, and agricultural biotechnology applications
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced degrees in biotechnology, biochemistry, or related fields, possessing knowledge of protein formulation, antibody design, and cross-disciplinary applications of pharmaceutical technologies
Obviousness Rationale
A PHOSITA would recognize the straightforward extension of the pharmaceutical composition's core elements to agricultural applications, given the well-established principles of antibody targeting and the known challenges in crop management. The specific combination of antibody, glycine, acetate buffer, and polysorbate 80 represents a predictable application of known pharmaceutical formulation techniques to address agricultural problems. The technical similarities between pharmaceutical and agricultural biotechnology domains would suggest that such a translation is a logical and obvious approach to solving crop-related challenges.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,625 |
|---|---|
| Title | Pharmaceutical compositions |
| Assignee(s) | UCB BIOPHARMA SRL |